Cubist Systematic Strategies, LLC Chroma Dex Corp. Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.36 - $3.84 $12,241 - $34,563	9,001 New	9,001 $31,000
Q4 2022 Feb 14, 2023	BUY	$1.25 - $1.94 $14,983 - $23,254	11,987 New	11,987 $20,000
Q2 2022 Aug 15, 2022	BUY	$1.59 - $2.7 $59,089 - $100,340	37,163 Added 142.26%	63,286 $106,000
Q1 2022 May 16, 2022	BUY	$2.02 - $3.92 $52,768 - $102,402	26,123 New	26,123 $64,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.41 $341,540 - $587,675	-56,453 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.66 - $10.92 $174,485 - $286,093	26,199 Added 86.6%	56,453 $557,000
Q1 2021 May 17, 2021	SELL	$4.59 - $18.74 $6,577 - $26,854	-1,433 Reduced 4.52%	30,254 $283,000
Q4 2020 Feb 16, 2021	BUY	$3.93 - $5.5 $21,697 - $30,365	5,521 Added 21.1%	31,687 $152,000
Q3 2020 Nov 16, 2020	BUY	$4.01 - $5.56 $19,661 - $27,260	4,903 Added 23.06%	26,166 $105,000
Q2 2020 Aug 14, 2020	BUY	$3.0 - $5.52 $63,789 - $117,371	21,263 New	21,263 $98,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $362M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.